S. DeRosa

发表

Lack of viral control and development of combination antiretroviral therapy escape mutations in macaques after bone marrow transplantation

Roger E Bumgarner, J. Mullins, Shiu-Lok Hu, 2015, AIDS.

Comparison of CyTOF assays across sites: Results of a six-center pilot study

Mark M. Davis, B. Walker, L. Olsen, 2017, Journal of immunological methods.

T Cell Responses against Mycobacterial Lipids and Proteins Are Poorly Correlated in South African Adolescents

Wenxin Jiang, R. Gottardo, N. Frahm, 2015, The Journal of Immunology.

Lentivirus-mediated Gene Transfer in Hematopoietic Stem Cells Is Impaired in SHIV-infected, ART-treated Nonhuman Primates.

Philip R. Gafken, Hannah W. Miller, Shiu-Lok Hu, 2015, Molecular therapy : the journal of the American Society of Gene Therapy.

Speci ﬁ city and 6-Month Durability of Immune Responses Induced by DNA and Recombinant Modi ﬁ ed Vaccinia Ankara Vaccines Expressing HIV-1 Virus-Like Particles

S. Hammer, B. Moss, S. Buchbinder, 2014 .

Longitudinal immune profiling after radiation-attenuated sporozoite vaccination reveals coordinated immune processes correlated with malaria protection

Fergal J. Duffy, E. Newell, J. Aitchison, 2022, Frontiers in Immunology.

Correction: Decreased Pre-existing Ad5 Capsid and Ad35 Neutralizing Antibodies Increase HIV-1 Infection Risk in the Step Trial Independent of Vaccination

S. Buchbinder, M. McElrath, G. Nabel, 2012, PLoS ONE.

Decreased Pre-existing Ad5 Capsid and Ad35 Neutralizing Antibodies Increase HIV-1 Infection Risk in the Step Trial Independent of Vaccination

S. Buchbinder, M. McElrath, G. Nabel, 2012, PloS one.

Safety and Immunogenicity of a Third Dose of SARS-CoV-2 mRNA Vaccine – An Interim Analysis

J. Mascola, D. Montefiori, R. Coler, 2022, Research square.

Comparative Immunogenicity of HIV-1 gp140 Vaccine Delivered by Parenteral, and Mucosal Routes in Female Volunteers; MUCOVAC2, A Randomized Two Centre Study

S. McCormack, D. Montefiori, N. Frahm, 2016, PloS one.

Safety and Immunogenicity of a Recombinant Adenovirus Serotype 35-Vectored HIV-1 Vaccine in Adenovirus Serotype 5 Seronegative and Seropositive Individuals.

H. Liao, B. Haynes, J. Fuchs, 2015, Journal of AIDS & clinical research.

Lack of viral control and development of cART escape mutations in macaques after bone marrow transplantation

Roger E Bumgarner, J. Mullins, H. Kiem, 2015 .

Loss of immune homeostasis dictates SHIV rebound after stem-cell transplantation.

R. Sékaly, Shiu-Lok Hu, Clarisse Benne, 2017, JCI insight.

Phase 1 safety and immunogenicity testing of DNA and recombinant modified vaccinia Ankara vaccines expressing HIV-1 virus-like particles.

W. Blattner, B. Moss, D. Montefiori, 2011, The Journal of infectious diseases.

Specificity and 6-month durability of immune responses induced by DNA and recombinant modified vaccinia Ankara vaccines expressing HIV-1 virus-like particles.

S. Hammer, B. Moss, D. Montefiori, 2014, The Journal of infectious diseases.

Positive selection of mC46-expressing CD4+ T cells and maintenance of virus specific immunity in a primate AIDS model.

Shiu-Lok Hu, H. Kiem, G. Trobridge, 2013, Blood.

Multiple factors affect immunogenicity of DNA plasmid HIV vaccines in human clinical trials.

Xuesong Yu, David C Montefiori, Georgia D Tomaras, 2015, Vaccine.

Predictors of HVTN 503 MRK-AD5 HIV-1 gag/pol/nef Vaccine Induced Immune Responses

J. Kublin, L. Bekker, G. Gray, 2014, PloS one.

Comparison of CyTOF assays across sites: Results of a six-center pilot study

Lisa E. Wagar, Mark M. Davis, B. Walker, 2017, Journal of immunological methods.

Lentivirus-mediated Gene Transfer in Hematopoietic Stem Cells Is Impaired in SHIV-infected, ART-treated Nonhuman Primates.

Philip R. Gafken, Hannah W. Miller, Shiu-Lok Hu, 2015, Molecular therapy : the journal of the American Society of Gene Therapy.